Published in Biochem J on May 15, 1995
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Calcium release from the sarcoplasmic reticulum. Physiol Rev (1977) 10.59
Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol (1988) 7.57
Purification and reconstitution of the calcium release channel from skeletal muscle. Nature (1988) 6.67
Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature (1989) 6.07
Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature (1993) 5.69
Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Physiol (1987) 4.61
Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol (1988) 4.56
Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem (1990) 4.35
Kinetics of rapid Ca2+ release by sarcoplasmic reticulum. Effects of Ca2+, Mg2+, and adenine nucleotides. Biochemistry (1986) 4.08
Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant. Nature (1983) 3.94
Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+. J Gen Physiol (1986) 3.55
Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum. J Biol Chem (1984) 3.34
Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature (1985) 3.13
Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem (1991) 3.10
The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol (1993) 2.64
G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci (1994) 2.57
Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures. J Biol Chem (1987) 2.32
Mechanisms of Ca2+ release from sarcoplasmic reticulum of skeletal muscle. Physiol Rev (1984) 2.03
Purified ryanodine receptor of skeletal muscle sarcoplasmic reticulum forms Ca2+-activated oligomeric Ca2+ channels in planar bilayers. Proc Natl Acad Sci U S A (1988) 1.89
Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal Biochem (1985) 1.75
Pyruvate carboxylase: affinity labelling of the magnesium adenosine triphosphate binding site. Eur J Biochem (1976) 1.62
Inactivation of the sarcoplasmic reticulum calcium channel by protein kinase. Nature (1992) 1.62
Evidence for a junctional feet-ryanodine receptor complex from sarcoplasmic reticulum. Biochem Biophys Res Commun (1987) 1.36
Fast release of calcium from sarcoplasmic reticulum vesicles monitored by chlortetracycline fluorescence. J Biochem (1983) 1.33
Ryanodine sensitivity of the calcium release channel of sarcoplasmic reticulum. Cell Calcium (1988) 1.27
Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. Biochim Biophys Acta (1993) 1.24
Pharmacology of calcium release from sarcoplasmic reticulum. J Bioenerg Biomembr (1989) 1.20
Nucleotide regulation of ATP sensitive potassium channels. Cardiovasc Res (1994) 1.07
Enhancement of Ca2+ release channel activity by phosphorylation of the skeletal muscle ryanodine receptor. FEBS Lett (1993) 1.06
Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases. Biochem J (1993) 1.03
Rapid filtration studies of Ca2+-induced Ca2+ release from skeletal sarcoplasmic reticulum. Role of monovalent ions. J Biol Chem (1988) 1.00
Characterization and photoaffinity labeling of the ATP binding site of the ryanodine receptor from skeletal muscle. Eur J Biochem (1993) 0.89
Activation and inhibition of the calcium-release channel of isolated skeletal muscle heavy sarcoplasmic reticulum. Models of the calcium-release channel. Eur J Biochem (1990) 0.86
Adenosine(5')hexaphospho(5')adenosine stimulation of a Ca(2+)-induced Ca(2+)-release channel from skeletal muscle sarcoplasmic reticulum. Eur J Biochem (1992) 0.83
2',3'-Dialdehyde GTP as an irreversible G protein antagonist. Disruption and reconstitution of G protein-mediated signal transduction in cells and cell membranes. J Biol Chem (1994) 0.81
2',3'-Dialdehyde ATP analog labels the Ca(2+)-ATPase of sarcoplasmic reticulum via the catalytic adenosine-nucleotide-binding site. Eur J Biochem (1992) 0.79
Structural and functional characterization of the interaction between 2',3'-dialdehyde guanine nucleotide analogues and the stimulatory G protein alpha-subunit. J Biol Chem (1994) 0.78
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochim Biophys Acta (1995) 4.67
The skeletal muscle chloride channel in dominant and recessive human myotonia. Science (1992) 4.28
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70
Membrane changes in cells from myotonia patients. Physiol Rev (1985) 2.38
A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet (1994) 2.22
Probing protein-protein interactions in real time. Nat Struct Biol (2000) 2.12
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve (1987) 1.94
[Osteosynthesis of the temporal articular tubercle]. Rev Stomatol Chir Maxillofac (2007) 1.91
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology (2007) 1.90
Cells involved in the immune response. IV. The response of normal and immune rabbit bone marrow and lymphoid tissue lymphocytes to antigens in vitro. J Exp Med (1968) 1.89
Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol (1993) 1.88
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology (2010) 1.84
Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain (2001) 1.82
Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release. J Physiol (2000) 1.76
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
Absolute pulse energy measurements of soft x-rays at the Linac Coherent Light Source. Opt Express (2014) 1.73
A surface active protein involved in aerial hyphae formation in the filamentous fungus Schizophillum commune restores the capacity of a bald mutant of the filamentous bacterium Streptomyces coelicolor to erect aerial structures. Mol Microbiol (1998) 1.71
Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J (2005) 1.64
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature (1990) 1.57
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
Myotonia fluctuans. Arch Neurol (1990) 1.56
Pulsed-field gel electrophoresis for epidemiologic studies of Campylobacter hyointestinalis isolates. J Clin Microbiol (1992) 1.55
Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis (1994) 1.54
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve (2000) 1.50
Cells involved in the immune response. VI. The immune response to red blood cells in irradiated rabbits after administration of normal, primed, or immune allogeneic rabbit bone marrow cells. J Exp Med (1969) 1.48
[Staging laparoscopy in Hodgkin's disease. A valid alternative to staging laparotomy]. Dtsch Med Wochenschr (1993) 1.44
Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve (1984) 1.44
The use of Poller screws as blocking screws in stabilising tibial fractures treated with small diameter intramedullary nails. J Bone Joint Surg Br (1999) 1.44
The use of radiolabelled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients. Cephalalgia (2006) 1.41
Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve (1983) 1.39
[Headache, hypertension]. Schweiz Rundsch Med Prax (1991) 1.38
Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J Physiol (1995) 1.36
Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol (1994) 1.33
Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet (1994) 1.32
Ion channels and epilepsy. Am J Med Genet (2001) 1.32
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta (1996) 1.29
Regulation of the purified Ca2+ release channel/ryanodine receptor complex of skeletal muscle sarcoplasmic reticulum by luminal calcium. Pflugers Arch (1996) 1.29
The response of leucocytes of agammaglobulinaemia subjects to phythohaemagglutinin and anti-immunoglobulin antiserum. Clin Exp Immunol (1969) 1.29
Paramyotonia congenita: the R1448P Na+ channel mutation in adult human skeletal muscle. Ann Neurol (1996) 1.28
A novel SCN4A mutation causing myotonia aggravated by cold and potassium. Hum Mol Genet (1993) 1.26
Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet (2001) 1.25
H2-forming methylenetetrahydromethanopterin dehydrogenase, a novel type of hydrogenase without iron-sulfur clusters in methanogenic archaea. Eur J Biochem (1992) 1.24
Maternal weight and pregnancy complications. Am J Obstet Gynecol (1985) 1.23
High agreement on family affluence between children's and parents' reports: international study of 11-year-old children. J Epidemiol Community Health (2008) 1.23
Role in fast inactivation of the IV/S4-S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis. J Physiol (1997) 1.22
Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci (2001) 1.19
Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology (2004) 1.17
A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol (1999) 1.17
Trauma care in Germany. Injury (2003) 1.16
Seasonality of weather and tree phenology in a tropical evergreen mountain rain forest. Int J Biometeorol (2006) 1.16
Active fascial contractility: Fascia may be able to contract in a smooth muscle-like manner and thereby influence musculoskeletal dynamics. Med Hypotheses (2005) 1.16
The role of bone marrow in the immune response. Adv Immunol (1970) 1.16
Cells involved in the immune response. XXII. The demonstration of thymus-specific antigens in the rabbit. Immunology (1972) 1.15
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis (2007) 1.15
The variation in response of human peripheral lymphocytes to phytohemagglutinin in vitro. Int Arch Allergy Appl Immunol (1967) 1.15
Overexcited or inactive: ion channels in muscle disease. Cell (1995) 1.15
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs (2006) 1.15
Photoelectric effect at ultrahigh intensities. Phys Rev Lett (2007) 1.13
Drug-induced myotonia in human intercostal muscle. Muscle Nerve (1988) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
[Inadequate treatment compliance, patient information and drug prescription as causes for emergency hospitalization of patients with chronic heart failure]. Schweiz Med Wochenschr (1993) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
The resting membrane parameters of human intercostal muscle at low, normal, and high extracellular potassium. Muscle Nerve (1984) 1.10
Similarity of primary radical pair recombination in photosystem II and bacterial reaction centers. FEBS Lett (1993) 1.10
Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology (2006) 1.10
Altered sodium channel behaviour causes myotonia in dominantly inherited myotonia congenita. Neuromuscul Disord (1991) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H) FEBS Lett (1998) 1.07
Functional magnetic resonance imaging with intermolecular multiple-quantum coherences. Magn Reson Imaging (2000) 1.07
Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol (1995) 1.06
Improvement of pain and function after arthroscopy and arthrocentesis of the temporomandibular joint: a comparative study. J Craniomaxillofac Surg (2000) 1.06
Adynamia episodica hereditaria: what causes the weakness? Muscle Nerve (1989) 1.05
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Membrane defects in paramyotonia congenita with and without myotonia in a warm environment. Muscle Nerve (1981) 1.05
A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. J Physiol (2000) 1.05
Voltage-activated calcium signals in myotubes loaded with high concentrations of EGTA. Biophys J (2003) 1.05
Computer-assisted analysis of lower limb geometry: higher intraobserver reliability compared to conventional method. Comput Aided Surg (2006) 1.04
Cells involved in the immune response. I. The response of normal rabbit bone marrow cells to antigens in vitro. Int Arch Allergy Appl Immunol (1968) 1.04
Absorption and excretion of furosemide-S35 in human subjects. Proc Soc Exp Biol Med (1966) 1.03
Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases. Biochem J (1993) 1.03
Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem (1997) 1.02
Structural proteins involved in emergence of microbial aerial hyphae. Fungal Genet Biol (1999) 1.02
Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995. Neuromuscul Disord (1997) 1.02
Role in fast inactivation of conserved amino acids in the IV/S4-S5 loop of the human muscle Na+ channel. Neurosci Lett (1996) 1.01
On identification of Na(+) channel gating schemes using moving-average filtered hidden Markov models. Eur Biophys J (1999) 1.01
Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.01
Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy. Neurology (2011) 1.00